CFO Devender Gupta exits; Vinod Goel takes over as Group CFO

Cfo ResignedKmp ResignedManagement Changes View source PDF Explain this filing

PANACEABIO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.3%Reaction day

₹356.30

prior close

₹358.20

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.6%-0.7% vs market

Pharmaceuticals peers, median of 159sector-0.4%-0.9% vs sector

On the reaction day the stock moved 0.7 pts less than Nifty Microcap 250 and 0.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.5

10m

-1.5

15m

-1.0

30m

-0.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.3-0.6-0.7-0.4-0.9

Next day

-2.3-1.5-0.8-1.2-1.1

-3.2-1.8-1.3-1.3-1.9

-0.2-0.6+0.4-0.4+0.2

+0.7+0.8-0.1+0.1+0.6

+0.1+0.8-0.7+0.3-0.1

+14.8-0.2+15.0-0.7+15.5

15d

+7.5+1.1+6.4+0.9+6.6

+12.5-3.5+16.0-2.6+15.1

-2.6-3.2+0.6-4.3+1.7

-10.7-12.8+2.1-11.5+0.9

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 159Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mr. Devender Gupta ceased as CFO of Panacea Biotec from December 15, 2025. Existing Group CFO Mr. Vinod Goel, who also held the Company Secretary role, has been formally appointed as Chief Financial Officer and Head Legal and Corporate Governance from December 16, 2025. Mr. Ankit Jain has been appointed as the new Company Secretary and Compliance Officer.

Likely market impact

CFO position filled internally. Smooth KMP transition with no expected disruption for shareholders.